Topic: Neurosciences

2015 Approvals Herald Rapid Progress, Growing Diversity in Precision Medicine

The Personalized Medicine Coalition (PMC) reports that 13 of 45 new molecular entities or therapeutic biologics approved by FDA in 2015, or 28%, were personalized medicines. The number of approved personalized (precision) medicines increased from 9 in 2014. While completing the transition to precision medicine will take years and require addressing major challenges, the momentum… Read more »

Mitigating Risk in Neurosciences Studies with e-Source Assessments

The case for electronic data capture in neurosciences studies is strong. The high failure rate in CNS development, headlined by a series of failed Alzheimer’s studies, is one reason to seek better methods. According to a Scientific American article by Kenneth Kaitin and Christopher Milne of the Tufts Center for the Study of Drug Development,… Read more »